Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Verastem (VSTM) over the last 3 years, with Sep 2025 value amounting to $144.1 million.

  • Verastem's Total Non-Current Liabilities rose 111.83% to $144.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.1 million, marking a year-over-year increase of 111.83%. This contributed to the annual value of $72.2 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Verastem's Total Non-Current Liabilities stood at $144.1 million, which was up 4.07% from $138.5 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Total Non-Current Liabilities registered a high of $144.1 million during Q3 2025, and its lowest value of $68.0 million during Q3 2024.
  • Its 3-year average for Total Non-Current Liabilities is $100.7 million, with a median of $90.8 million in 2024.
  • In the last 5 years, Verastem's Total Non-Current Liabilities fell by 5.21% in 2024 and then skyrocketed by 111.83% in 2025.
  • Verastem's Total Non-Current Liabilities (Quarterly) stood at $71.8 million in 2023, then fell by 5.21% to $72.2 million in 2024, then skyrocketed by 111.83% to $144.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $144.1 million for Q3 2025, versus $138.5 million for Q2 2025 and $109.4 million for Q1 2025.